NCT04955158View on ClinicalTrials.gov

Dexmedetpmidine Versus Ketamine for Postoperative Sore Throat in Sinus Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

143

Participants

Timeline

Start Date

August 19, 2021

Primary Completion Date

February 1, 2023

Study Completion Date

February 15, 2023

Conditions
Sore Throat
Interventions
DRUG

Dexmedetomidine

75 µg dexmedetomidine soaked pharyngeal pack (Group D) putted in the posterior pharyngeal wall after induction of anesthesia and ETT.

DRUG

Ketamine

50 mg ketamine soaked pharyngeal pack (Group K) putted in the posterior pharyngeal wall after induction of anesthesia and ETT.

OTHER

saline 0.9%

20 ml 0.9% saline soaked pharyngeal pack (Group C) putted in the posterior pharyngeal wall after induction of anesthesia and ETT.

Trial Locations (1)

Assuit universi

Omar Soliman, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT04955158 - Dexmedetpmidine Versus Ketamine for Postoperative Sore Throat in Sinus Surgery | Biotech Hunter | Biotech Hunter